Serum levels of calcitonin gene-related peptide and substance P are decreased in patients with diabetes mellitus and coronary artery disease

Journal of International Medical Research

Volumn 40, Issue 1, 2012, Pages 134-140

  Wang, L H ^a   Zhou, S X ^a   Li, R C ^b   Zheng, L R ^a   Zhu, J H ^a   Hu, S J ^a   Sun, Yi Lan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Hangzhou Yuhang Hospital of Traditional Chinese Medicine   (China)

Author keywords

Calcitonin gene related peptide; Coronary artery disease; Diabetes mellitus; Substance P

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GLUCOSE; SUBSTANCE P;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; RADIOIMMUNOASSAY;

EID: 84863287243     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000114     Document Type: Article

References (30)

1. Grundy SM, Benjamin IJ, Burke GL, et al: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134-1146.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
3. Bartnik M, Rydén L, Ferrari R, et al: The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880-1890.
4. Hu DY, Pan CY, Yu JM, et al: The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J 2006; 27: 2573-2579.
5. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, 2005.
6. Kruglikov I, Gryshchenko O, Shutov L, et al: Diabetes-induced abnormalities in ER calcium mobilization in primary and secondary nociceptive neurons. Pflugers Arch 2004; 448: 395-401.
7. Song JX, Wang LH, Yao L, et al: Impaired transient receptor potential vanilloid 1 in streptozotocin-induced diabetic hearts. Int J Cardiol 2009; 134: 290-292.
8. Wang L, Wang DH: TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation 2005; 112: 3617-3623.
9. Howden CW, Logue C, Gavin K, et al: Haemodynamic effects of intravenous human calcitonin-gene-related peptide in man. Clin Sci (Lond) 1988; 74: 413-418.
10. Hu CP, Xiao L, Deng HW, et al: The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts. Planta Med 2002; 68: 705-709.
11. Wei Z, Wang L, Han J, et al: Decreased expression of transient receptor potential vanilloid 1 impairs the postischemic recovery of diabetic mouse hearts. Circ J 2009; 73: 1127-1132.
12. Middleton J: Experience with a glucose-oxidase method for estimating glucose in blood and C.S.F. Br Med J 1959; 1: 824-826.
13. Manzini S, Perretti F, De Benedetti L, et al: A comparison of bradykinin-and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of substance P and calcitonin gene-related peptide release. Br J Pharmacol 1989; 97: 303-312.
14. Hoover DB: Effects of capsaicin on release of substance P-like immunoreactivity and physiological parameters in isolated perfused guinea-pig heart. Eur J Pharmacol 1987; 141: 489-492.
15. Franco-Cereceda A, Saria A, Lundberg JM: Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain. Acta Physiol Scand 1989; 135: 173-187.
16. Milner P, Ralevic V, Hopwood AM, et al: Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia. Experientia 1989; 45: 121-125.
17. Lundberg JM, Franco-Cereceda A, Hua X, et al: Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol 1985; 108: 315-319.
18. Hoover DB, Hossler FE: Vasoconstrictor and dilator responses to neurokinin A in isolated guinea pig heart. Peptides 1993; 14: 29-36.
19. Zahner MR, Li DP, Chen SR, et al: Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats. J Physiol 2003; 551: 515-523.
20. Saito A, Kimura S, Goto K: Calcitonin generelated peptide as potential neurotransmitter in guinea pig right atrium. Am J Physiol 1986; 250: H693-H698.
21. Sugiyama A, Kobayashi M, Tsujimoto G, et al: The first demonstration of CGRPimmunoreactive fibers in canine hearts: coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated, blood-perfused heart preparations. Jpn J Pharmacol 1989; 50: 421-427.
22. Uren NG, Seydoux C, Davies GJ: Effect of intravenous calcitonin gene related peptide on ischaemia threshold and coronary stenosis severity in humans. Cardiovasc Res 1993; 27: 1477-1481.
23. Wang Z, Guo J, Wang X: A study for the relationship between serum calcitonin generelated peptide and coronary arteriopathy. Zhonghua Nei Ke Za Zhi 2001; 40: 750-752 [in Chinese, English abstract].
24. Lechleitner P, Genser N, Mair J, et al: Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction. Am Heart J 1992; 124: 1433-1439.
25. Pittenger GL, Ray M, Burcus NI, et al: Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 2004; 27: 1974-1979.
26. Schmidt RE, Plurad SB: Ultrastructural and biochemical characterization of autonomic neuropathy in rats with chronic streptozotocin diabetes. J Neuropathol Exp Neurol 1986; 45: 525-544.
27. Faerman I, Faccio E, Milei J, et al: Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes 1977; 26: 1147-1158.
28. Claus D, Feistel H, Brunhölzl C, et al: Investigation of parasympathetic and sympathetic cardiac innervation in diabetic neuropathy: heart rate variation versus metaiodo-benzylguanidine measured by single photon emission computed tomography. Clin Auton Res 1994; 4: 117-123.
29. Donnelly R, Emslie-Smith AM, Gardner ID, et al: ABC of arterial and venous disease: vascular complications of diabetes. BMJ 2000; 320: 1062-1066.
30. Huxley R, Barzi F, Woodward M: Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332: 73-78.